Enovis Price to Free Cash Flow Ratio 2010-2024 | ENOV
Enovis Price to Free Cash Flow Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
2024-11-19 | 45.27 | 0.00 | |
2024-09-30 | 43.05 | $-1.26 | 0.00 |
2024-06-30 | 45.20 | $-1.49 | 0.00 |
2023-12-31 | 56.02 | $0.83 | 67.34 |
2023-09-30 | 52.73 | $-1.32 | 0.00 |
2023-06-30 | 64.12 | $-3.51 | 0.00 |
2023-03-31 | 53.49 | $-3.39 | 0.00 |
2022-12-31 | 53.52 | $-3.85 | 0.00 |
2024-03-31 | 62.45 | $-2.92 | 0.00 |
2022-09-30 | 46.07 | $-0.09 | 0.00 |
2022-06-30 | 55.00 | $1.15 | 47.82 |
2022-03-31 | 68.49 | $3.13 | 21.87 |
2021-12-31 | 79.12 | $5.06 | 15.63 |
2021-09-30 | 79.00 | $5.79 | 13.65 |
2021-06-30 | 78.85 | $5.63 | 14.00 |
2021-03-31 | 75.40 | $5.01 | 15.04 |
2020-12-31 | 65.82 | $4.31 | 15.25 |
2020-09-30 | 53.98 | $2.98 | 18.09 |
2020-06-30 | 48.02 | $2.44 | 19.66 |
2020-03-31 | 34.08 | $3.00 | 11.36 |
2019-12-31 | 62.62 | $0.29 | 214.00 |
2019-09-30 | 50.02 | $2.18 | 22.95 |
2019-06-30 | 48.24 | $3.08 | 15.65 |
2019-03-31 | 51.08 | $2.73 | 18.70 |
2018-12-31 | 35.97 | $4.76 | 7.56 |
2018-09-30 | 62.07 | $3.85 | 16.11 |
2018-06-30 | 52.75 | $2.98 | 17.71 |
2018-03-31 | 54.91 | $3.33 | 16.47 |
2017-12-31 | 68.19 | $4.14 | 16.46 |
2017-09-30 | 71.67 | $5.46 | 13.13 |
2017-06-30 | 67.76 | $5.63 | 12.03 |
2017-03-31 | 67.57 | $5.34 | 12.65 |
2016-12-31 | 61.84 | $4.65 | 13.30 |
2016-09-30 | 54.10 | $4.22 | 12.81 |
2016-06-30 | 45.54 | $5.21 | 8.74 |
2016-03-31 | 49.21 | $5.94 | 8.28 |
2015-12-31 | 40.19 | $5.62 | 7.15 |
2015-09-30 | 51.48 | $6.83 | 7.54 |
2015-06-30 | 79.43 | $8.66 | 9.18 |
2015-03-31 | 82.15 | $9.15 | 8.98 |
2014-12-31 | 88.76 | $7.37 | 12.04 |
2014-09-30 | 98.06 | $8.56 | 11.45 |
2014-06-30 | 128.30 | $7.22 | 17.77 |
2014-03-31 | 122.77 | $7.59 | 16.18 |
2013-12-31 | 109.62 | $8.69 | 12.62 |
2013-09-30 | 97.23 | $8.09 | 12.02 |
2013-06-30 | 89.69 | $6.62 | 13.55 |
2013-03-31 | 80.10 | $6.70 | 11.96 |
2012-12-31 | 69.45 | $2.99 | 23.21 |
2012-09-30 | 63.12 | $-0.70 | 0.00 |
2012-06-30 | 47.45 | $-0.83 | 0.00 |
2012-03-31 | 60.65 | $-1.86 | 0.00 |
2011-12-31 | 49.02 | $2.95 | 16.62 |
2011-09-30 | 34.87 | $3.70 | 9.41 |
2011-06-30 | 42.69 | $3.38 | 12.63 |
2011-03-31 | 39.50 | $2.57 | 15.36 |
2010-12-31 | 31.69 | $3.40 | 9.31 |
2010-09-30 | 25.59 | $1.89 | 13.54 |
2010-06-30 | 17.92 | $2.61 | 6.87 |
2010-03-31 | 20.26 | $2.35 | 8.61 |
2009-12-31 | 20.72 | $1.93 | 10.72 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $2.529B | $1.707B |
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $8.497B | 0.00 |
Inspire Medical Systems (INSP) | United States | $5.276B | 164.53 |
Hims & Hers Health (HIMS) | United States | $5.141B | 130.72 |
Privia Health (PRVA) | United States | $2.533B | 211.10 |
IRhythm Technologies (IRTC) | United States | $2.362B | 0.00 |
Azenta (AZTA) | United States | $2.001B | 99.78 |
Omnicell (OMCL) | United States | $1.964B | 64.26 |
Clover Health Investments (CLOV) | United States | $1.644B | 0.00 |
10x Genomics (TXG) | United States | $1.643B | 0.00 |
Schrodinger (SDGR) | United States | $1.378B | 0.00 |
Phreesia (PHR) | United States | $1.072B | 0.00 |
Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
Standard BioTools (LAB) | United States | $0.562B | 0.00 |
Talkspace (TALK) | United States | $0.522B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.520B | 0.00 |
Definitive Healthcare (DH) | United States | $0.483B | 83.60 |
Health Catalyst (HCAT) | United States | $0.459B | 0.00 |
TruBridge (TBRG) | United States | $0.244B | 71.22 |
Pulmonx (LUNG) | United States | $0.237B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.214B | 0.00 |
American Well (AMWL) | United States | $0.122B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.107B | 0.00 |
P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
HeartBeam (BEAT) | United States | $0.067B | 0.00 |
111 (YI) | China | $0.053B | 0.00 |
CareCloud (CCLD) | United States | $0.046B | 0.00 |
Zepp Health (ZEPP) | China | $0.040B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
Outset Medical (OM) | United States | $0.039B | 0.00 |
Movano (MOVE) | United States | $0.020B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.014B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |